Fig. 2From: The effect of recombinant human soluble thrombomodulin on renal function and mortality in septic disseminated intravascular coagulation patients with acute kidney injury: a retrospective studyKaplan–Meier survival curves for septic DIC patients with AKI assigned to the rhTM and non-rhTM groups. The green and blue lines represent patients in the rhTM and non-rhTM groups, respectively. The rhTM treatment was associated with a significantly higher survival rate (P = 0.009). AKI, acute kidney injury; rhTM, recombinant human soluble thrombomodulinBack to article page